Antimicrobial Susceptibility Patterns inPseudomonas aeruginosa:Data from a Multicenter Intensive Care Unit Surveillance Study (ISS) in the United States-Reference-Cited by-同舟云学术

Antimicrobial Susceptibility Patterns inPseudomonas aeruginosa:Data from a Multicenter Intensive Care Unit Surveillance Study (ISS) in the United States

Published:2004-10 Issue:5 Volume:16 Page:437-441
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Friedland I.,Gallagher G.,King T.,Woods G.L.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference17 articles.

1. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from October 1986–April 1998, Issued June 1998

2. β-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa

3. Acquired carbapenemases

4. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa

5. Expression of Pseudomonas aeruginosa Multidrug Efflux Pumps MexA-MexB-OprM and MexC-MexD-OprJ in a Multidrug-Sensitive Escherichia coli Strain

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa;Molecular Therapy - Methods & Clinical Development;2024-12

2. Resilience and Charge-Dependent Fibrillation of Functional Amyloids: Interactions ofPseudomonasBiofilm-Associated FapB and FapC;2024-02-14

3. Quinolones as antimicrobial and antiresistance agents;Antibiotics - Therapeutic Spectrum and Limitations;2023

4. In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration;Journal of Controlled Release;2019-06

5. In vitro Effects of Magnesium-Aluminum Hydroxide (Maalox) on the Antibacterial Activity of Ciprofloxacin against Clinical Bacterial Isolates;Journal of Pure and Applied Microbiology;2018-06-30